BZLF1 (ZEBRA, Zta) Protein of Epstein-Barr Virus Selected in a Yeast One-Hybrid System by Binding to a Consensus Site in the IgH Intronic Enhancer: A Role in Immunoglobulin Expression?

Biological Chemistry Hoppe-Seyler

Volumn 377, Issue 10, 1996, Pages 669-674

  Gstaiger, Matthias ^a   Hovens, Christopher ^a   Georgiev, Oleg ^a   Knoepfel, Lea ^a   Schaffner, Walter ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; DNA LIBRARY; ENHANCER REGION; EPSTEIN BARR VIRUS; IMMUNOGLOBULIN GENE; INTRON; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION; YEAST;

CONSENSUS SEQUENCE; ENHANCER ELEMENTS (GENETICS); HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INTRONS; SACCHAROMYCES CEREVISIAE;

HUMAN HERPESVIRUS 4; MAMMALIA;

EID: 0029858709     PISSN: 01773593     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm3.1996.377.10.669     Document Type: Article

References (38)

1. Banerji, J., Olson, L., and Schaffner, W. (1983). A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33, 729–740.
2. Chan, W. Y., Liu, Q. R., Borjigin, J., Busch, H., Rennert, O. M., Tease, L. A., and Chan, P. K. (1989). Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28.1033–1039.
3. Cho, M. S., Milman, G., and Hayward, S. D. (1985). A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein. J. Virol. 56,860–866.
4. Corcoran, L. M., and Karvelas, M. (1994). Oct-2 is required early in T cell-independent B cell activation for G1 progression and for proliferation. Immunity 1,635–645.
5. Corcoran, L. M., Karvelas, M., Nossal, G. J., Ye, Z. S., Jacks, T., and Baltimore, D. (1993). Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7,570–582.
6. Countryman, J., and Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogenous viral DNA. Proc. Natl. Acad. Sci. USA, 82,4085–4089.
7. Dundr, M., Leno, G. H., Hammarskjöld, M. L., Rekosh, D., Helga, M. C., and Olson, M. O. (1995). The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein. J. Cell Sci. 708,2811–2823.
8. Ephrussi, A., Church, G., Tonegawa, S., and Gilbert, W. (1985). B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227,134–140.
9. Farrell, P. J., Rowe, D. T., Rooney, C. M., and Kouzarides, T. (1989). Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 8,127–132.
10. Felber, B. K., Hadzopoulou, C. M., Cladaras, C., Copeland, T., and Pavlakis, G. N. (1989). Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86,1495–1499.
11. Gerster, T., Matthias, P., Thali, M., Jiricny, J., and Schaffner, W. (1987). Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer. EMBO J. 6,1323–1330.
12. Gillies, S. D., Morrison, S. L., Oi, V. T., and Tonegawa, S. (1983). A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33,717–728.
13. Gstaiger, M., Knoepfel, L., Georgiev, O., Schaffner, W., and Hovens, C. M. (1995). A B-cell coactivator of octamer-binding transcription factors. Nature 373,360–362.
14. Gutsch, D. E., Holley-Guthrie, E. A., Zhang, Q., Stein, B., Blanar, M. A., Baldwin, A. S., and Kenney, S. C. (1994). The bZlP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kB. Mol. Cell. Biol. 14, 1939–1948.
15. Hagman, J., and Grosschedl, R. (1994). Regulation of gene expression at early stages of B-cell differentiation. Current Biology 6,222–230.
16. Hammerschmidt, W., and Sugden, B. (1988). Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55,427–433.
17. Henthorn, P., Kiledjian, M., and Kadesch, T. (1990). Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science 247,467–470.
18. Kieff, E., and Liebowitz, D. (1990). Epstein-Barr virus and its replication. In: Virology, Vol. 2, B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath and B. Roizman, Eds. (New York: Raven Press), pp. 1889–1920.
19. Lieberman, P. M., and Berk, A. J. (1990). In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein. J. Virol. 64,2560–2568.
20. Luo, Y., and Roeder, R. G. (1995). Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 75,4115–4124.
21. Malim, M. H., Hauber, J., Le, S. Y., Maizel, J. V., and Cullen, B. R. (1989). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338,254–257.
22. Miller, G. (1990). Epstein-Barr virus. In: Virology, Vol. 2, B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath and B. Roizman, Eds. (New York: Raven Press), pp. 1921–1958.
23. Müller, M. M., Ruppert, S., Schaffner, W., and Matthias, P. (1988). A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature 336, 544–551.
24. Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S. D., and Clearly, M. L. (1990). Chromosomal translocation t(1; 19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60, 535–545.
25. Rochford, R., and Mosier, D. E. (1995). Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J. Virol. 69,150–155.
26. Rose, M., and Botstein, D. (1983). Structure and function of the yeast URA3 gene. Differentially regulated expression of hybrid beta-galactosidase from overlapping coding sequences in yeast. J. Mol. Biol. 170,883–904.
27. Schepers, A., Pich, D., and Hammerschmidt, W. (1993). A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO J. 72,3921–3929.
28. Schepers, A., Pich, D., and Hammerschmidt, W. (1996). Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 220,367–376.
29. Schepers, A., Schmid, R. M., Drouet, E., and Hammerschmidt, W. (1996). Functional antagonisms between RelA and BZLF1 transrepress lytic viral functions of Epstein-Barr virus. In press.
30. Staudt, L. M., and Lenardo, M. J. (1991). Immunoglobulin gene transcription. Annu. Rev. Immunol. 9,373–398.
31. Stein, B., Baldwin, A., Jr., Ballard, D. W., Greene, W. C., Angel, P., and Herrlich, P. (1993). Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J., 12,3879–3891.
32. Stein, B., Cogswell, P. C., and Baldwin, A., Jr. (1993). Functional and physical associations between NF-kappa B and C/EBP family members: a Rei domain-bZIP interaction. Mol. Cell. Biol. 73,3964–3974.
33. Strubin, M., Newell, J. W., and Matthias, P. (1995). OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80,497–506.
34. Szebeni, A., Herrera, J. E., and Olson, M. O. (1995). Interaction of nucleolar protein B23 with peptides related to nuclear localization signals. Biochemistry 34,8037–8042.
35. Takada, K., Shimizu, N., Sakuma, S., and Ono, Y. (1986). Trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA frag ment. J. Virol. 57,1016–1022.
36. Takada, K., and Ono, Y. (1989). Synchronous and sequential activation of latently infected Epstein-Barr virus genomes, J. Virol. 63,445–449.
37. Westin, G., Gerster, T., Muller, M. M., Schaffner, G., and Schaffner, W. (1987). OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts. Nucleic Acids Res. 75, 6787–6798.
38. Zhuang, Y., Soriano, P., and Weintraub, H. (1994). The helix-loop-helix gene E2A is required for B cell formation. Cell 79, 875–884.